
Fortress Biotech
FBIOP | NASDAQ
$13.86
-$0.50 (-3.48%)
At close: Nov 16, 2026, 4:00 PM ET
$13.86
$0.00 (-0.04%)
After-hours:
Nov 16, 2026, 4:10 PM ET
-3.48%
(1D)No price chart data available for 1D timeframe.
Rating
46.5
-3.0 ptsFundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #353/1021 (Top 35%)
Key Statistics
Market Data
Market Cap $57.07M
1D Range
13.68 14.62
52W Range
6.53 21.08
Valuation (TTM)
PE -
PB 0.36
EV/EBITDA -0.39
Valuation (NTM)
Forward PE 5.63
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield 220.3%
SBC Adj. FCF Yield 216.0%
SBC Impact -2.0%
Margins
Gross Margin 63.2%
Operating Margin -42.5%
FCF Margin 179.7%
Growth (CAGR)
Revenue 3Y | 5Y -4.7% |
1.7%
Dil EPS 3Y | 5Y 546.7% |
78.2%
FCF 3Y | 5Y 801.5% |
92.2%
Returns
ROA 35.7%
ROE 74.7%
ROIC -13.1%
Financial Health
Net Cash
$124.1M
Current Ratio 2.93
Interest Coverage -3.28
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a minoc...
Sector Healthcare
Industry Biotechnology
Employees 78
IPO Date Nov 14, 2017
Website www.fortressbiotech.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 13, 2026
EPS
-$0.23
Beat +14.81%
YoY:
-309.09% REV
$19.16M
Miss -11.20%
YoY:
+8.67%Next Earnings
Apr 1, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove FBIOP